21-Mar-2026 4:40 PM CST - The Motley Fool DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but it also means giving up some upside when risk appetite shifts toward early-stage biotech companies.
17-Mar-2026 3:30 AM CST - Seeking Alpha iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.1218 Payable Mar 20; for shareholders of record Mar 17; ex-div Mar 17. More on iShares Biotechnology ETF IBB: Beyond The 2025 Surge, Biotech Breakout IBB: Biotech's Hot Streak May Cool Most and least shorted mid-to mega-cap healthcare stocks in February Most and least shorted healthcare stocks with up
4-Mar-2026 7:35 AM CST - Seeking Alpha Most and least shorted mid-to mega-cap healthcare stocks in February The healthcare sector is facing aggressive short selling, particularly targeting high-growth disruptors while avoiding major pharmaceutical companies. As of late February, short interest in volatile a
13-Feb-2026 7:35 AM CST - Seeking Alpha Most and least shorted mid-to mega-cap healthcare stocks in January Amid heightened market volatility, the healthcare sector (XLV) has become a battleground for short sellers, with biotechnology and healthcare services emerging as the primary targets. At the center of this bearish siege is Hims & Hers (HIMS),
27-Jan-2026 3:10 AM CST - Seeking Alpha IBB: Beyond The 2025 Surge, Biotech Breakout Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.
26-Jan-2026 4:22 AM CST - Seeking Alpha IBB: Biotech's Hot Streak May Cool IBB ETF analysis: hold rating as biotech consolidates near highs. Fair 19x P/E, low EPS growth and weak seasonality shape risk/reward.
9-Jan-2026 11:50 AM CST - Yahoo Finance Here's Why Biotech ETFs Are Rallying Hard Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.
23-Dec-2025 12:03 PM CST - The Motley Fool IBIT vs. ETHA: How Bitcoin and Ethereum Shape Crypto ETF Risk Both funds offer regulated crypto exposure, but bitcoin and ethereum behave differently in volatility and capital flows, shaping how each ETF fits inside a portfolio
20-Dec-2025 1:00 PM CST - The Motley Fool 3 Best Bitcoin ETF Picks for 2026 Bitcoin experienced a lot of volatility in 2025 without much in the way of total return. How is 2026 shaping up for Bitcoin ETFs?
21-Mar-2026 4:40 PM CST - The Motley Fool DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but it also means giving up some upside when risk appetite shifts toward early-stage biotech companies.
17-Mar-2026 3:30 AM CST - Seeking Alpha iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.1218 Payable Mar 20; for shareholders of record Mar 17; ex-div Mar 17. More on iShares Biotechnology ETF IBB: Beyond The 2025 Surge, Biotech Breakout IBB: Biotech's Hot Streak May Cool Most and least shorted mid-to mega-cap healthcare stocks in February Most and least shorted healthcare stocks with up
4-Mar-2026 7:35 AM CST - Seeking Alpha Most and least shorted mid-to mega-cap healthcare stocks in February The healthcare sector is facing aggressive short selling, particularly targeting high-growth disruptors while avoiding major pharmaceutical companies. As of late February, short interest in volatile a
13-Feb-2026 7:35 AM CST - Seeking Alpha Most and least shorted mid-to mega-cap healthcare stocks in January Amid heightened market volatility, the healthcare sector (XLV) has become a battleground for short sellers, with biotechnology and healthcare services emerging as the primary targets. At the center of this bearish siege is Hims & Hers (HIMS),
27-Jan-2026 3:10 AM CST - Seeking Alpha IBB: Beyond The 2025 Surge, Biotech Breakout Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.
26-Jan-2026 4:22 AM CST - Seeking Alpha IBB: Biotech's Hot Streak May Cool IBB ETF analysis: hold rating as biotech consolidates near highs. Fair 19x P/E, low EPS growth and weak seasonality shape risk/reward.
9-Jan-2026 11:50 AM CST - Yahoo Finance Here's Why Biotech ETFs Are Rallying Hard Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.
23-Dec-2025 12:03 PM CST - The Motley Fool IBIT vs. ETHA: How Bitcoin and Ethereum Shape Crypto ETF Risk Both funds offer regulated crypto exposure, but bitcoin and ethereum behave differently in volatility and capital flows, shaping how each ETF fits inside a portfolio
20-Dec-2025 1:00 PM CST - The Motley Fool 3 Best Bitcoin ETF Picks for 2026 Bitcoin experienced a lot of volatility in 2025 without much in the way of total return. How is 2026 shaping up for Bitcoin ETFs?
